Patient Guide: A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 16 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT06961370
Status: 🟢 Enrolling Now
Condition: Geographic Atrophy, Age-related Macular Degeneration
Phase: PHASE1

Where You Can Participate

This study is available at 16 locations across the country.

Top locations include:
  • • Phoenix, Arizona
  • • Sun City, Arizona
  • • Beverly Hills, California
  • • And 13 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD), and Immunogenicity of RO7669330 in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) - Join Clinical Trial NCTNCT06961370

How to Join This Clinical Trial - NCTNCT06961370

Learn how to participate in this PHASE1 trial studying an investigational therapy for Geographic Atrophy, Age-related Macular Degeneration. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Geographic Atrophy, Age-related Macular Degeneration. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Geographic Atrophy, Age-related Macular Degeneration
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT06961370 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 16 locations. Find a study site near you:

Clinical Research Site

Phoenix, Arizona 85020-5505 - United States

Status: RECRUITING

Clinical Research Site

Sun City, Arizona 85351 - United States

Status: RECRUITING

Clinical Research Site

Beverly Hills, California 90211 - United States

Status: RECRUITING

Clinical Research Site

Glendale, California 91204 - United States

Status: RECRUITING

Clinical Research Site

Sacramento, California 95825 - United States

Status: RECRUITING

Clinical Research Site

Augusta, Georgia 30909 - United States

Status: RECRUITING

Clinical Research Site

Hagerstown, Maryland 21740 - United States

Status: RECRUITING

Clinical Research Site

Saint Louis, Missouri 63128 - United States

Status: RECRUITING

Clinical Research Site

Portland, Oregon 97221 - United States

Status: RECRUITING

Clinical Research Site

Erie, Pennsylvania 16505 - United States

Status: RECRUITING

And 6 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Geographic Atrophy, Age-related Macular Degeneration:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships